AI
LinkedIn on CUBT
Dr. Bharti is on the Scientific Advisory Board of Curative Biotechnology (CUBT)
Kapil Bharti • 2nd Translational Scientist | Senior Investigator NIH | Team Leader | Innovator Cell and Gene Therapies, and Vision Research |
This clinical trial for oral metformin as a treatment for Stargardt disease is a perfect example of bench-to-bedside collaboration between my lab Mitra Farnoodian Francesca Barone Ruchi Sharma in my group testing metformin on patient iPSC-RPE and animal models, and my clinician colleague Brian Brooks taking the drug to patients.
We will soon be launching a safety and feasibility trial for AMD with metformin eye drops, a collaboration with Richard Garr at Curative Biotech.
https://www.linkedin.com/feed/update/urn:li:activity:6919657458894258176/
Dr. Bharti is on the Scientific Advisory Board of Curative Biotechnology (CUBT)
Kapil Bharti • 2nd Translational Scientist | Senior Investigator NIH | Team Leader | Innovator Cell and Gene Therapies, and Vision Research |
This clinical trial for oral metformin as a treatment for Stargardt disease is a perfect example of bench-to-bedside collaboration between my lab Mitra Farnoodian Francesca Barone Ruchi Sharma in my group testing metformin on patient iPSC-RPE and animal models, and my clinician colleague Brian Brooks taking the drug to patients.
We will soon be launching a safety and feasibility trial for AMD with metformin eye drops, a collaboration with Richard Garr at Curative Biotech.
https://www.linkedin.com/feed/update/urn:li:activity:6919657458894258176/
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
